The use of a predictive statistical model to make a virtual control arm for a clinical trial
Switchenko, Jeffrey M, Heeke, Arielle L, Pan, Tony C, Read, William L
Published in PloS one (04.09.2019)
Published in PloS one (04.09.2019)
Get full text
Journal Article
Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity
Menon, Ambika, Enunwa, Chidiebele A., Read, William L., James, Kyle P.
Published in Case reports in oncology (01.01.2024)
Published in Case reports in oncology (01.01.2024)
Get full text
Journal Article
Differential Prognostic Impact of Comorbidity
READ, William L, TIERNEY, Ryan M, PAGE, Nathan C, COSTAS, Irene, GOVINDAN, Ramaswamy, SPITZNAGEL, Edward L. J, PICCIRILLO, Jay F
Published in Journal of clinical oncology (01.08.2004)
Published in Journal of clinical oncology (01.08.2004)
Get full text
Journal Article
Conference Proceeding
A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma
McElroy, Michele K., MD, Read, William L., MD, Harmon, Gregory S., MD, Weidner, Noel, MD
Published in Annals of diagnostic pathology (01.10.2011)
Published in Annals of diagnostic pathology (01.10.2011)
Get full text
Journal Article
Atezolizumab for Advanced Alveolar Soft Part Sarcoma
Chen, Alice P., Sharon, Elad, O’Sullivan-Coyne, Geraldine, Moore, Nancy, Foster, Jared C., Hu, James S., Van Tine, Brian A., Conley, Anthony P., Read, William L., Riedel, Richard F., Burgess, Melissa A., Glod, John, Davis, Elizabeth J., Merriam, Priscilla, Naqash, Abdul R., Fino, Kristin K., Miller, Brandon L., Wilsker, Deborah F., Begum, Asma, Ferry-Galow, Katherine V., Deshpande, Hari A., Schwartz, Gary K., Ladle, Brian H., Okuno, Scott H., Beck, Jill C., Chen, James L., Takebe, Naoko, Fogli, Laura K., Rosenberger, Christina L., Parchment, Ralph E., Doroshow, James H.
Published in The New England journal of medicine (07.09.2023)
Published in The New England journal of medicine (07.09.2023)
Get full text
Journal Article
A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma
Somaiah, Neeta, Van Tine, Brian Andrew, Wahlquist, Amy E., Milhem, Mohammed M., Hill, Elizabeth G., Garrett‐Mayer, Elizabeth, Armeson, Kent E., Schuetze, Scott M., Meyer, Christian F., Reuben, Daniel Y., Elias, Anthony D., Read, William L., Chawla, Sant P., Kraft, Andrew S.
Published in Cancer (15.03.2021)
Published in Cancer (15.03.2021)
Get full text
Journal Article
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Rosenbaum, Evan, Chugh, Rashmi, Ryan, Christopher W., Agulnik, Mark, Milhem, Mohammed M., George, Suzanne, Jones, Robin L., Chmielowski, Bartosz, Van Tine, Brian A., Tawbi, Hussein, Elias, Anthony D., Read, William L., Budd, G. Thomas, Qin, Li-Xuan, Rodler, Eve T., Hirman, Joe, Weiden, Paul, Bennett, Cathryn M., Livingston, Philip O., Ragupathi, Govind, Hansen, David, D'Angelo, Sandra P., Tap, William D., Schwartz, Gary K., Maki, Robert G., Carvajal, Richard D.
Published in European journal of cancer (1990) (01.11.2022)
Published in European journal of cancer (1990) (01.11.2022)
Get full text
Journal Article
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
Holdhoff, Matthias, Ye, Xiaobu, Supko, Jeffrey G, Nabors, Louis B, Desai, Arati S, Walbert, Tobias, Lesser, Glenn J, Read, William L, Lieberman, Frank S, Lodge, Martin A, Leal, Jeffrey, Fisher, Joy D, Desideri, Serena, Grossman, Stuart A, Wahl, Richard L, Schiff, David
Published in Neuro-oncology (Charlottesville, Va.) (01.06.2017)
Published in Neuro-oncology (Charlottesville, Va.) (01.06.2017)
Get full text
Journal Article
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin
Lorza, Andres M. Arias, Ravi, Harshan, Philip, Rohit C., Galons, Jean-Philippe, Trouard, Theodore P., Parra, Nestor A., Von Hoff, Daniel D., Read, William L., Tibes, Raoul, Korn, Ronald L., Raghunand, Natarajan
Published in Scientific reports (02.09.2020)
Published in Scientific reports (02.09.2020)
Get full text
Journal Article
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression
Huang, Raymond Y, Unadkat, Prashin, Bi, Wenya Linda, George, Elizabeth, Preusser, Matthias, McCracken, Jay D, Keen, Joseph R, Read, William L, Olson, Jeffrey J, Seystahl, Katharina, Le Rhun, Emilie, Roelcke, Ulrich, Koeppen, Susanne, Furtner, Julia, Weller, Michael, Raizer, Jeffrey J, Schiff, David, Wen, Patrick Y
Published in Neuro-oncology (Charlottesville, Va.) (14.02.2019)
Published in Neuro-oncology (Charlottesville, Va.) (14.02.2019)
Get full text
Journal Article
Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
McCracken, D. Jay, Celano, Emma C., Voloschin, Alfredo D., Read, William L., Olson, Jeffrey J.
Published in Journal of neuro-oncology (01.10.2016)
Published in Journal of neuro-oncology (01.10.2016)
Get full text
Journal Article
Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
Read, William L., Brumund, Kevin T., Weisman, Robert A., Nguyen, Angel Q.
Published in JAAD Case Reports (01.05.2015)
Published in JAAD Case Reports (01.05.2015)
Get full text
Journal Article